Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02657369
Title A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eisai Inc.
Indications
Therapies
Age Groups:
Covered Countries USA | ITA | GBR | FRA | AUS

Facility Status City State Zip Country Details
Scottsdale Arizona 85259 United States Details
Duarte California 91010 United States Details
Washington District of Columbia 20007 United States Details
Washington District of Columbia 20010 United States Details
Jacksonville Florida 32224 United States Details
Miami Florida 33136 United States Details
Boston Massachusetts 02114 United States Details
Boston Massachusetts 02215 United States Details
Rochester Minnesota 55905 United States Details
New York New York 10065-6007 United States Details
Durham North Carolina 27710 United States Details
Portland Oregon 97239 United States Details
Philadelphia Pennsylvania 19104 United States Details
Houston Texas 77030 United States Details
Camperdown New South Wales 2050 Australia Details
St Leonards New South Wales Australia Details
Caen cedex 05 Calvados 14076 France Details
Bordeaux Gironde 33076 France Details
Angers Cedex 9 Maine Et Loire 49933 France Details
Lyon Cedex 08 Rhone 69373 France Details
Lyon Rhone 69008 France Details
Villejuif cedex Val De Marne 94805 France Details
Milano 20133 Italy Details
Milano 20162 Italy Details
Pisa 56124 Italy Details
Roma 00161 Italy Details
Siena 53100 Italy Details
Cardiff South Glamorgan CF14 2TL United Kingdom Details
Glasgow Strathclyde G12 OYN United Kingdom Details
Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field